| |
| |
|
| Insider
Information: |
Patel Snehal |
| Relationship: |
CEO and CFO, Director,... |
| City: |
Stafford |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,350,777 |
|
|
Indirect Shares
|
2,712,886 |
|
|
| Direct
Value |
$76,944,173 |
|
|
|
Indirect Value
|
$39,011,301 |
|
|
| Total
Shares |
8,063,663 |
|
|
| Total
Value |
$115,955,474 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Greenwich Lifesciences, Inc. |
GLSI |
CEO and CFO, Director,... |
2024-04-01 |
5,350,777 |
2022-06-24 |
2,712,886 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GLSI |
Greenwich Lifesciences, I... |
CHIEF EXECUTIVE OFFICEROfficer |
• • – |
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
749,336 |
|
- |
|
| GLSI |
Greenwich Lifesciences, I... |
CHIEF EXECUTIVE OFFICEROfficer |
• • – |
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,232,284 |
|
- |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-02-17 |
4 |
B |
$16.53 |
$9,918 |
D/D |
600 |
2,736,486 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-01-13 |
4 |
B |
$19.99 |
$19,990 |
D/D |
1,000 |
1,194,429 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-09-29 |
4 |
B |
$9.23 |
$9,230 |
D/D |
1,000 |
2,713,886 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-09-30 |
4 |
B |
$9.46 |
$9,460 |
D/D |
1,000 |
2,714,886 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-12-02 |
4 |
B |
$13.84 |
$13,840 |
D/D |
1,000 |
2,722,886 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-12-16 |
4 |
B |
$13.01 |
$13,010 |
D/D |
1,000 |
2,725,886 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-02-10 |
4 |
B |
$18.68 |
$18,680 |
D/D |
1,000 |
2,735,886 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-03-10 |
4 |
B |
$12.12 |
$12,120 |
D/D |
1,000 |
2,737,486 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-05-17 |
4 |
B |
$11.69 |
$11,690 |
D/D |
1,000 |
5,287,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-07-21 |
4 |
B |
$9.20 |
$9,200 |
D/D |
1,000 |
5,288,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-08-22 |
4 |
B |
$9.97 |
$9,970 |
D/D |
1,000 |
5,291,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-09-11 |
4 |
B |
$9.48 |
$9,480 |
D/D |
1,000 |
5,292,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-10-10 |
4 |
B |
$9.07 |
$9,070 |
D/D |
1,000 |
5,299,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-01-06 |
4 |
B |
$15.18 |
$22,770 |
D/D |
1,500 |
2,731,386 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-01-20 |
4 |
B |
$17.37 |
$26,055 |
D/D |
1,500 |
2,732,886 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-20 |
4 |
B |
$17.68 |
$26,520 |
D/D |
1,500 |
5,345,277 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2021-12-14 |
4 |
B |
$27.17 |
$49,992 |
D/D |
1,840 |
1,191,379 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • – |
2020-11-19 |
4 |
B |
$5.40 |
$10,795 |
D/D |
2,000 |
1,186,839 |
2.81 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-10-07 |
4 |
B |
$9.72 |
$19,440 |
D/D |
2,000 |
2,716,886 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-11-02 |
4 |
B |
$8.79 |
$17,580 |
D/D |
2,000 |
2,721,886 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-12-09 |
4 |
B |
$13.11 |
$26,220 |
D/D |
2,000 |
2,724,886 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-01-27 |
4 |
B |
$19.35 |
$38,700 |
D/D |
2,000 |
2,734,886 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-04-18 |
4 |
B |
$11.12 |
$22,240 |
D/D |
2,000 |
5,279,177 |
3.15 |
% |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
